Health Care: Drugs

Bio-Techne Corp (TECH: NASDAQ)

$105.4 n/a | n/a%
12/02/16 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 105.40
52 Week High 117.42
52 Week Low 79.95
Avg. Daily Vol. (Mil) 0.17
Beta (3 year) 0.83
Share Related Items
Mkt Cap (Mil) 3,932.44
Shares Out (Mil) 37.31
Float (Mil) 36.77
Dividend Information
Yield % 1.20
Annual Dividend 1.28
Payout Ratio 49.00
Financial Strength
Quick Ratio 3.50
Current Ratio 4.70
LT Debt/ Equity 0.10
Total Debt / Equity 0.11
Valuation Ratios
Price Earnings 40.20
Price/Sales 7.60
Price/Book 4.47
Price/Cash Flow 26.70
Per Share Data
Earnings 2.62
Sales 13.86
Book Value 23.57
Cash Flow 3.95
Business Summary
Bio-Techne Corp and its subsidiaries develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products. The Company's business segments are the Biotechnology, Clinical Controls and Protein Platforms divisions.
General Information
614 McKinley Place North Eas
Minneapolis, MN 55413-2610
www.bio-techne.com
Industry : Drugs
Sector: Health Care
Employees: 1560
CEO: Mr. Charles R. Kummeth
Short Interest
Current Month (Mil) 1.51
Previous Month (Mil) 1.47
Short Interest Ratio (Days) 9.50
Management Effectiveness
Return on Equity 11.90
Return on Assets 9.20
Return on Investments 10.80
Profitability
Gross Margin 76.00
EBIT Margin 29.90
Profit Margin 19.00

Portfolios with TECH

Latest TECH Headlines from TheStreet

More Financial News for TECH

Press Releases for TECH

See All Press Releases

Partner Headlines for TECH

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter